Skip to content
2000
Volume 9, Issue 6
  • ISSN: 1389-5575
  • E-ISSN: 1875-5607

Abstract

Available anti-obesity pharmacotherapy options remain very limited. The development of more effective drugs has become a priority. The potential strategies to achieve weight loss are to reduce energy intake, by stimulating anorexigenic signals or by blocking orexigenic signals, and to increase energy expenditure. This review will focus on approved obesity medications, as well as potential new pharmacological treatment options.

Loading

Article metrics loading...

/content/journals/mrmc/10.2174/138955709788452739
2009-06-01
2024-12-28
Loading full text...

Full text loading...

/content/journals/mrmc/10.2174/138955709788452739
Loading

  • Article Type:
    Research Article
Keyword(s): drug treatment; ghrelin; leptin; Obesity; orlistat; rimonabant; sibutramine
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test